13642-52-9|Soterenol|Methanesulfonamide, N-(2-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-|-范德生物科技公司

Soterenol

NMR下载 COA and HPLC MSDS下载
names：
Methanesulfonamide, N-(2-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-
CAS号：
13642-52-9
MDL Number：
MF(分子式)： C12H20N2O4S MW(分子量)： 288.362
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)
FMK19704-100mg	100mg	>98%	¥ 0.00	¥ 0.00		Get quote	- +	¥ 0.00

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Methanesulfonamide, N-(2-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-
英文别名	Soterenol; Soterenolum
CAS号	13642-52-9
Inchi	InChI=1S/C12H20N2O4S/c1-8(2)13-7-12(16)9-4-5-11(15)10(6-9)14-19(3,17)18/h4-6,8,12-16H,7H2,1-3H3
InchiKey	HHRNQOGXBRYCHF-UHFFFAOYSA-N
分子式 Formula	C12H20N2O4S
分子量 Molecular Weight	288.362
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Soterenol(CAS:13642-52-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Soterenol is an adrenergic beta-2 agonist used as bronchodilator and has a number of gastrointestinal side effects.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Borda E, del C Agostini M, Gimeno MF, Gimeno AL. Selective stimulation of PGE1-synthesis by soterenol in the isolated rat vas deferens is mediated by alpha adrenoreceptors. Prostaglandins Leukot Med. 1982 May;8(5):531-6. PubMed PMID: 6285389.

[2]Kensler TT, Brooke D, Walker DM. Application of trihydroxyindole reaction to methanesulfonanilides: fluorometric analysis for soterenol and mesuprine. J Pharm Sci. 1976 May;65(5):763-4. PubMed PMID: 6778.

[3] Kitagawa H, Yamauchi A, Shibata S. Potent alpha-adrenoceptor action of soterenol on vascular and other smooth muscle. Eur J Pharmacol. 1975 Aug;33(1):227-30. PubMed PMID: 240730.

[4] Keh GS, Kearney PE, Raper C. Comparison of the beta-adrenoceptor effects of soterenol and its 3-hydroxy, 4-sulphonamido isomer (MJ6987-1) in isolated tissues from the guninea-pig. Clin Exp Pharmacol Physiol. 1979 Jul-Aug;6(4):409-13. PubMed PMID: 39696.

[5] Malta E, Raper C. Influence of changes in amine substitution on the beta-adrenoceptor stimulant activity of soterenol and related compounds in the anaesthetized cat. Clin Exp Pharmacol Physiol. 1975 Jul-Aug;2(4):359-63. PubMed PMID: 238779.

6: Farmer JB, Levy GP, Marshall RJ. A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline. J Pharm Pharmacol. 1970 Dec;22(12):945-7. PubMed PMID: 4395522.7: Dungan KW, Cho YW, Gomoll AW, Aviado DM, Lish PM. Pharmacologic potency and selectivity of a new bronchodilator agent: soterenol (MJ 1992). J Pharmacol Exp Ther. 1968 Dec;164(2):290-301. PubMed PMID: 5699090.8: Buckner CK, Saini RK. On the use of functional antagonism to estimate dissociation constants for beta adrenergic receptor agonists in isolated guinea-pig trachea. J Pharmacol Exp Ther. 1975 Sep;194(3):565-74. PubMed PMID: 240019.9: Farmer JB, Levy GP. Comparative beta-adrenoceptive stimulant properties of salbutamol (AH 3365), orciprenaline and soterenol (MJ 1992). Br J Pharmacol. 1969 Feb;35(2):P358-9. PubMed PMID: 5774057; PubMed Central PMCID: PMC1703250.10: Farmer JB, Kennedy I, Levy GP, Marshall RJ. A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig. J Pharm Pharmacol. 1970 Jan;22(1):61-3. PubMed PMID: 4391750.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开